Clinical significance of massive proteinuria in primary IgA nephropathy with and without nephrotic syndrome: a single center cohort study

被引:3
|
作者
Hu, Ya [1 ,2 ]
Huang, Ziyuan [1 ,2 ]
Cao, Qianqian [1 ]
Chen, Bo [1 ,2 ]
Xu, Shungang [1 ,2 ]
Qiu, Wenxian [1 ,2 ]
You, Xiaohan [1 ,2 ]
Zhang, Ji [1 ,2 ]
Chen, Chaosheng [1 ,2 ,3 ]
机构
[1] Wenzhou Med Univ, Affifiliated Hosp 1, Dept Nephrol, Wenzhou, Zhejiang, Peoples R China
[2] Wenzhou Med Univ, Inst Chron Kidney Dis, Wenzhou, Zhejiang, Peoples R China
[3] Wenzhou Med Univ, Dept Nephrol, Affifiliated Hosp 1, Wenzhou 325000, Zhejiang, Peoples R China
关键词
IgA nephropathy; nephrotic syndrome; proteinuria; OXFORD CLASSIFICATION;
D O I
10.1080/0886022X.2023.2267138
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Both primary IgA nephropathy (IgAN) with and without nephrotic syndrome (NS) can present massive proteinuria (24-h urinary protein >= 3.5 g/d). The clinical significance of massive proteinuria may be different in the two entities and needs further research.Methods: Data of 1870 patients with biopsy-proven IgAN in our hospital from January 2011 to December 2022 was retrospectively reviewed. A total of 242 IgAN patients with massive proteinuria were enrolled. Patients who presented with nephrotic syndrome at renal biopsy were included in the IgAN with NS cohort (IgAN-NS). The IgAN with nephrotic-range proteinuria cohort (IgAN-NR) consisted of 1:1 matched cases from the remaining according to age, gender, estimated glomerular filtration rate (eGFR) at baseline, and follow-up time. The clinical and pathological characteristics between the two cohorts were analyzed.Results: The IgAN-NS had a significantly higher proteinuria level than the IgAN-NR (p < .001). Cluster analysis revealed that proteinuria was associated with lipids in IgAN-NS, while it was associated with inflammatory indicators in IgAN-NR. When the complete remission of proteinuria (CR) was not achieved, the Kaplan-Meier analysis showed the prognosis of IgAN-NS was significantly worse than that of IgAN-NR (p = .04). Then, our GLMM model and line chart showed that the serum albumin level of the IgAN-NR was always evidently higher than that of the IgAN-NS while the significant difference in urinary albumin/creatinine ratio between the two cohorts gradually disappeared during the short-term follow-up (1 year). Moreover, the Cox regression analysis showed that the increased serum albumin was an independent protective factor for the poor outcomes (eGFR decreased from the baseline >= 30% continuously or reached end-stage renal disease [ESRD]).Conclusion: The IgAN-NS had poorer clinicopathologic manifestation than IgAN-NR, including severer massive proteinuria. When the CR was not achieved, the prognosis of IgAN-NS was inferior to that of the IgAN-NR.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] CHRONIC TONSILLITIS AND IGA NEPHROPATHY - CLINICAL-STUDY OF PATIENTS WITH AND WITHOUT TONSILLECTOMY
    IINO, Y
    AMBE, K
    KATO, Y
    NAKAI, A
    TORIYAMA, M
    SAIMA, K
    YOSHIMOTO, K
    ACTA OTO-LARYNGOLOGICA, 1993, : 29 - 35
  • [32] Study of steroid-resistant nephrotic syndrome: a single center experience
    Elbeltagi, Youmna Ahmed Hassan
    El Kersh, Mahmoud Mohi El Din
    Fathy, Hanan Mohammad
    Kamel, Nancy Abdel-Salam
    EGYPTIAN PEDIATRIC ASSOCIATION GAZETTE, 2024, 72 (01)
  • [33] Clinical characterization of polycythemia vera associated with IgA nephropathy in a single Chinese center: A case series
    Wang, Xia
    Yang, Nannan
    Lu, Chunyu
    Xu, Feng
    Wang, Jinquan
    MEDICINE, 2023, 102 (14) : E33493
  • [34] Immunosuppressive therapy in children with primary nephrotic syndrome: single center experience, Karachi, Pakistan
    Khemchand Netaram Moorani
    Harnam Moolchand Hotchandani
    Aasia Mohammad Zubair
    Neelesh Chander Lohana
    Nanga Ram Veerwani
    BMC Nephrology, 20
  • [35] Immunosuppressive therapy in children with primary nephrotic syndrome: single center experience, Karachi, Pakistan
    Moorani, Khemchand Netaram
    Hotchandani, Harnam Moolchand
    Zubair, Aasia Mohammad
    Lohana, Neelesh Chander
    Veerwani, Nanga Ram
    BMC NEPHROLOGY, 2019, 20
  • [36] Efficacy and safety of rituximab for primary nephrotic syndrome with acute kidney injury: A two-center prospective cohort study
    Xu, Yili
    Huang, Yiqing
    Zhang, Chengning
    Sun, Lianqin
    Sun, Zhuxing
    Wang, Liang
    Zhang, Bo
    Yuan, Yanggang
    Xing, Changying
    Mao, Huijuan
    CLINICAL IMMUNOLOGY, 2023, 246
  • [37] Effect of tonsillectomy combined with steroid pulse therapy upon IgA nephropathy depending on proteinuria status at diagnosis: a nationwide multicenter cohort study in Japan
    Komatsu, Hiroyuki
    Fujimoto, Shouichi
    Sato, Yuji
    Yasuda, Takashi
    Yasuda, Yoshinari
    Matsuzaki, Keiichi
    Hirano, Keita
    Kawamura, Tetsuya
    Yokoo, Takashi
    Suzuki, Yusuke
    Maruyama, Shoichi
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2024, 28 (12) : 1272 - 1281
  • [38] Clinical Outcome of Hyperuricemia in IgA Nephropathy: A Retrospective Cohort Study and Randomized Controlled Trial
    Shi, Yongjun
    Chen, Wei
    Jalal, Diana
    Li, Zhibin
    Chen, Wenfang
    Mao, Haiping
    Yang, Qiongqiong
    Johnson, Richard J.
    Yu, Xueqing
    KIDNEY & BLOOD PRESSURE RESEARCH, 2012, 35 (03): : 153 - 160
  • [39] Sexual dimorphic response to rituximab treatment: A longitudinal observational study in a large cohort of patients with primary membranous nephropathy and persistent nephrotic syndrome
    Perna, Annalisa
    Ruggiero, Barbara
    Podesta, Manuel Alfredo
    Perico, Luca
    Orisio, Silvia
    Debiec, Hanna
    Remuzzi, Giuseppe
    Ruggenenti, Piero
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [40] Significance of clinical and morphological prognostic risk factors in IgA nephropathy: follow- up study of comparison patient groups with and without renoprotection
    Riispere, Zivile
    Kuudeberg, Anne
    Seppet, Elviira
    Sepp, Kristin
    Ilmoja, Madis
    Luman, Merike
    Kolvald, Kulli
    Auerbach, Asta
    Ots-Rosenberg, Mai
    BMC NEPHROLOGY, 2017, 18